In premenopausal women, denosumab significantly prevented bone loss and microarchitectural deterioration.
Grace Morrison, PharmD Candidate
Advertisement
Articles by Grace Morrison, PharmD Candidate
Combination treatment of sotorasib plus panitumumab prolongs progression-free survival in those with metastatic colorectal cancer and the KRAS G12C mutation.
Enfortumab vedotin in combination with pembrolizumab showed a manageable safety profile and promising progression free survival and overall survival for locally advanced or metastatic urothelial cancer.
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Cyclosporiasis Cases Reach 5100: Investigators Zero In On Lettuce, Possible Taco Bell Link
2
Gedatolisib Combination Approved for PIK3CA Wild-Type HR+, HER2– Breast Cancer
3
Subcutaneous Olanzapine in Schizophrenia: Expanding the Utility of a Proven Therapy
4
Rural Health Transformation Efforts Offer an Opportunity for Pharmacy to Shine
5